Combination of proton pump inhibitor and rebamipide, a free radical scavenger, promotes artificial ulcer healing after endoscopic submucosal dissection with dissection size >40 mm

Journal of Clinical Biochemistry and Nutrition

Volumn 51, Issue 3, 2012, Pages 185-188

  Araki, Hiroshi ^a   Kato, Tomohiro ^a,b   Onogi, Fumito ^a   Ibuka, Takashi ^a   Sugiyama, Akihiko ^b   Nakanishi, Takayuki ^a   Sugiyama, Tomohiko ^a   Tomita, Eiichi ^b   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY HOSPITAL   (Japan)

^b Gifu Municipal Hospital   (Japan)

Author keywords

Artificial ulcer; Endoscopic submucosal dissection (ESD); Proton pump inhibitor (PPI); Rebamipide; Ulcer healing

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; REBAMIPIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL ULCER; CONTROLLED STUDY; ENDOSCOPIC SUBMUCOSAL DISSECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; ULCER; ULCER HEALING;

EID: 84868609237     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.12-14     Document Type: Article

References (12)

1. Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer 2007; 10: 1-11. (Pubitemid 46356261)
2. 2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am J Gastroenterol 2007; 102: 1610-1616.
3. Okada K, Yamamoto Y, Kasuga A, et al. Risk factors for delayed bleeding after endoscopic submucosal dissection for gastric neoplasm. Surg Endosc 2011; 25: 98-107.
4. Takeuchi N, Umegaki E, Takeuchi T, Murano M, Yoda Y, Tokioka S, Higuchi K. Gastric ulcer healing after treatment of endoscopic submucosal dissection in Japanese: comparison of H2 receptor antagonist and proton pump inhibitor administration. J Clin Biochem Nutr 2011; 49: 216-221.
5. Kato T, Araki H, Onogi F, et al. Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection - a randomized controlled study. J Gastroenterol 2010; 45: 285-290.
6. Sakita T, Fukushima H. Endoscopic diagnosis. In: Yoshitoshi Y, ed. Ulcer of the Stomach and Duodenum (in Japanese). Tokyo: Nankodo, 1971; 198-208.
7. Fujiwara S, Morita Y, Toyonaga T, et al. A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection. J Gastroenterol 2011; 46: 595-602.
8. Terano A, Arakawa T, Sugiyama T, et al. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in Japanese population: a randomized, double-blind, placebo-controlled trial. J Gastroenterol 2007; 42: 690-693. (Pubitemid 47278695)
9. Tarnawski AS, Chai J, Pai R, Chiou SK. Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action? Dig Dis Sci 2004; 49: 202-209. (Pubitemid 38392218)
10. Takagi T, Naito Y, Uchiyama K, et al. Rebamipide promotes healing of colonic ulceration through enhanced epithelial restitution. World J Gastroenterol 2011; 17: 3802-3809.
11. Tanigawa T, Watanabe T, Ohkawa F, et al. Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase. J Clin Biochem Nutr 2011; 48: 149-153.
12. Yamamoto T, Isono A, Mishina Y, et al. Gastroduodenal mucosal injury in patients taking low-dose aspirin and the role of gastric mucoprotective drugs: possible effect of rebamipide. J Clin Biochem Nutr 2010; 47: 27-31.